Metossamina [DCIT] en es it fr

Metossamina [DCIT] Brand names, Metossamina [DCIT] Analogs

Metossamina [DCIT] Brand Names Mixture

  • No information avaliable

Metossamina [DCIT] Chemical_Formula

C11H17NO3

Metossamina [DCIT] RX_link

No information avaliable

Metossamina [DCIT] fda sheet

Metossamina [DCIT] msds (material safety sheet)

Metossamina_[DCIT] MSDS

Metossamina [DCIT] Synthesis Reference

No information avaliable

Metossamina [DCIT] Molecular Weight

211.258 g/mol

Metossamina [DCIT] Melting Point

No information avaliable

Metossamina [DCIT] H2O Solubility

Soluble (185 g/L)

Metossamina [DCIT] State

Solid

Metossamina [DCIT] LogP

1.5

Metossamina [DCIT] Dosage Forms

Liquid

Metossamina [DCIT] Indication

Indicated for the treatment and management of hypotension.

Metossamina [DCIT] Pharmacology

Methoxamine is a potent sympathomimetic amine that increases both systolic and diastolic blood pressure. Methoxamine is indicated for prevention and treatment of the acute hypotensive state occurring with spinal anesthesia. It is also indicated as adjunctive treatment of hypotension due to hemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to trauma or tumor. Methoxamine acts on both α1-adrenergic receptors but appears to have no effect on β-adrenergic receptors. It acts by increasing the force of the heart's pumping action as well as constricting peripheral blood vessels.

Metossamina [DCIT] Absorption

No information avaliable

Metossamina [DCIT] side effects and Toxicity

No information avaliable

Metossamina [DCIT] Patient Information

No information avaliable

Metossamina [DCIT] Organisms Affected

Humans and other mammals